MEROPENEM TAMRISA 500 mg, powder for solution for injection / for infusion 10 bottles of 20 ml
Active ingredients: Meropenem, Meropenem trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusion10 bottles of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MEROPENEM TAMRISA 500 mg, poudre pour solution injectable / pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- TAMRISA ACCESS (FRANCE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61137907CIP73019094CIP133400930190944Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉROPÉNEM TRIHYDRATÉpoudre | — | SA |
| MÉROPÉNEM ANHYDREpoudre | 500 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.